BYOOVIZ (ranibizumab-nuna) injection https://gafacom.website/byooviz-ranibizumab-nuna-injection/ Medicines

BYOOVIZ (ranibizumab-nuna) BYOOVIZ (ranibizumab-nuna) is a recombinant humanized IgG1 kappa isotype monoclonal antibody fragment designed for intraocular use. Ranibizumab-nuna binds to and inhibits the biologic activity of human vascular endothelial growth factor A (VEGF-A). Ranibizumab-nuna, which lacks an Fc region, has a molecular weight of approximately 48 kilodaltons and is produced by an E. coli …

BYOOVIZ (ranibizumab-nuna) injection Read More »

The post BYOOVIZ (ranibizumab-nuna) injection first appeared on Gafacom.